Sepragen Signs Agreement with Carbery Food Ingredients

Sepragen Corporation (Hayward, CA) has announced that it will license its patented Sepralac process to Carbery Food Ingredients, of Ballineen, Ireland, a leading European manufacturer of "high-end" dairy based food ingredients.

The Sepralac process uses radial flow chromatography (RFC) to separate proteins from dairy whey. The process can be used to fractionate whey into individual protein components or to produce a whey protein isolate. Depending on solubility, flavor, and texture characteristics, these individual fractions can then be used as functional and nutritional ingredients in a variety of foods, beverages, and other products. "Sepragen's technology will allow us to explore and develop emerging high value markets not only in infant nutrition but also in nutritional supplements related to muscle development, weight loss and health enhancement," said John Holland, Operations Director, Carbery Food Ingredients.

Carbery has tested the Sepralac process for more than a year and produced various products from whey, in particular alpha-lactalbumin, which has been supplied to certain leading infant formula companies for clinical testing. Published results have shown that the amino acid serum profile of infants fed with alpha-lactalbumin enriched formula is closer to that of breast-fed babies as compared with that of formula-fed babies.

Carbery's portfolio includes a variety of cheeses, food ingredients including protein isolates and infant formula ingredients, as well as lactose derived food grade alcohol.

Sepragen develops and sells processes and products using its proprietary radial flow chromatography systems for the dairy, citrus juice and biopharmaceutical markets.